Related Experiment Video
Updated: Jun 19, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Herpotrichone A Exerts Neuroprotective Effects by Relieving Ferroptosis
Jia-Le Deng1, Guo-Yan Wang2, Yi-Jie Zhai1
1Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, No.3 Taicheng Road, Yangling, Shaanxi 712100, China.
Herpotrichone A (He-A), derived from fungi, protects against neurodegenerative disease by inhibiting ferroptosis and oxidative stress. This compound shows promise for novel therapeutic strategies targeting neuronal damage.
Area of Science:
- Neuroscience
- Pharmacology
- Mycology
Background:
- Neurodegenerative diseases are linked to oxidative stress and ferroptosis.
- Herpotrichones, fungal compounds, show neuroprotective potential.
- The exact mechanisms of herpotrichone neuroprotection require further study.
Purpose of the Study:
- To isolate and characterize herpotrichone analogues from *Herpotrichia* sp. SF09.
- To evaluate the neuroprotective effects of herpotrichone A (He-A) and its analogues.
- To elucidate the mechanism of He-A's neuroprotection against ferroptosis.
Main Methods:
- Isolation of herpotrichones from *Herpotrichia* sp. SF09.
- Cell-based assays using PC12 and BV-2 cells stimulated with H2O2, 6-OHDA, RSL3, and LPS.
- Zebrafish models to assess ferroptotic cell death.
- Analysis of antioxidant element activation and SLC7A11 pathway modulation.
Main Results:
- Herpotrichone A (He-A) and analogues demonstrated significant protective effects in stimulated cell lines.
- He-A effectively reduced ferroptotic cell death in RSL3-treated PC12 cells and 6-OHDA-induced zebrafish.
- He-A activated antioxidant elements and modulated the SLC7A11 pathway without direct radical scavenging or iron chelation.
Conclusions:
- Herpotrichone A (He-A) exhibits potent neuroprotective properties against ferroptosis-like neuronal damage.
- He-A represents a novel therapeutic candidate for neurodegenerative diseases.
- The mechanism involves activating antioxidant pathways and modulating SLC7A11, distinct from direct antioxidant activity.
More Related Videos
13:12Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Published on: October 15, 2017
10:33Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Drugs Affecting Neurotransmitter Synthesis
Neurochemical Transmission: Sites of Drug Action
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...